Elm Street Ventures - aVenture Asset Manager Research
Location
New Haven, CT, US
Founded
2006
Elm Street Ventures (ESVC) is a venture capital firm focusing on creating and initially operating life sciences companies based on intellectual property from Yale University and other regional research institutions. The firm primarily invests in seed and early-stage ventures, leveraging its access to local, professionally managed venture capital to help scientists build significant technology companies.
Notable portfolio companies include Arvinas, Cybrexa, EvolveImmune Therapeutics, and P2 Science. ESVC's key partners are experienced serial entrepreneurs who provide strategic guidance and operational support to their portfolio companies. The firm's investment philosophy centers on fostering innovation in life sciences through close collaboration with academic institutions and leveraging regional research strengths.
Elm Street Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
540000Professional, Scientific, and Technical Services
525000Funds, Trusts, and Other Financial Vehicles
541000Professional, Scientific, and Technical Services
523910Miscellaneous Intermediation
523940Portfolio Management and Investment Advice
SIC
6000Depository Institutions
7300Business Services
Elm Street Ventures
Operating Status: Operating
ESVC is a venture capital firm, creating and operating life sciences companies based on regional research, with a focus on seed and early-stage ventures.
Series D1 (5.0%)
Stage Mix
Series A 50%Seed 30%Series B 10%Series C 5%Series D 5%
Concentration shown as share of disclosed investments by stage.